The stilbestrol-adenosis-carcinoma syndrome

Area of Science:

• Gynecology
• Oncology
• Epidemiology

Background:

• A novel disease complex emerged, first identified in 1966.
• Initial case reports in 1970 spurred intensive research into potential causes.
• The association with Diethylstilbestrol (DES) was established, leading to a case registry.

Purpose of the Study:

• To investigate the etiologic factors of a newly discovered disease complex.
• To verify the suspected link between Diethylstilbestrol (DES) exposure and the disease.
• To collect comprehensive data for understanding disease occurrence, behavior, and treatment response.

Main Methods:

• Epidemiological investigation of suspected etiologic factors.
• Establishment of a Registry of Cases for data collection.
• Analysis of clinical history and morphologic anomalies in exposed individuals.

Main Results:

• Confirmed the association between Diethylstilbestrol (DES) and the disease complex.
• Collected extensive data on disease occurrence and behavior.
• Demonstrated that localized tumors are curable with surgery or radiation therapy.

Conclusions:

• Diethylstilbestrol (DES) exposure is a significant risk factor for this disease complex.
• Screening is feasible for identifying at-risk individuals and detecting presymptomatic cancer.
• Early intervention offers a high chance of cure for localized disease.